欧洲下一代测序市场到 2025 年 - 按产品(平台、服务、消耗品)进行区域分析和预测;服务(基因组测序、外显子组测序、重测序、靶向测序和其他测序技术);应用(诊断、药物发现、精准医学和其他应用);和最终用户(学术和研究机构、制药和生物技术公司、医院诊所和其他最终用户)以及国家/地区

Historic Data: 2015-2016   |   Base Year: 2017   |   Forecast Period: 2018-2025


No. of Pages: 123    |    Report Code: TIPRE00005459    |    Category: Life Sciences

Europe Next Generation Sequencing Market

欧洲下一代测序市场预计将从 2017 年的 16.334 亿美元增至 2025 年的 76.854 亿美元。预计该市场自 2018 年起将以 21.4% 的复合年增长率增长-2025年。

市场的增长是由测序技术进步和基因组学发展等因素推动的。然而,由于该地区缺乏熟练的专业人员以及与下一代测序的遗传数据相关的高风险,该市场可能会受到影响。

领域的进步分子生物学同样增强了测序程序。过去几年,许多行业参与者提出了创新的 NGS 技术。克隆、基因测序、基因组工程等技术已导致转基因生物的产生。技术进步引领新生物经济的出现,它正在取代基于石化的制造和基于发酵的制造产品。例如,2018年10月,罗氏推出了三款新的下一代测序(NGS)AVENIO肿瘤组织分析试剂盒:AVENIO肿瘤组织靶向试剂盒、扩展试剂盒和监测试剂盒。该试剂盒可检测实体瘤中的所有四种突变类别,补充罗氏用于肿瘤学研究的 NGS ctDNA 试剂盒。此外,Pacific Biosciences 拥有 Sequel,Oxford Nanopore 拥有 PromethION。此外,主导市场的三种先进 NSG 系统包括 Roche GS FLX、Illumina HiSeq 2000 和 AB SOLiD。

NGS 使基于序列的基因表达分析成为一种“数字化”分析。模拟技术的替代方案。它还有助于利用微阵列的广度和 qPCR 的分辨率来量化 RNA 表达。基因组测序的进步为制药和农业等大多数行业增加了各种解决方案。这些技术进步可能会在不久的将来扩大市场。因此,技术进步预计将为市场带来创新治疗方法,从而推动欧洲下一代测序市场在预测年内的增长。


预计德国由于该国资金的增加和癌症患者数量的增加,该公司将引领欧洲地区的市场。此外,对研发的日益关注有助于推动预测期内的市场增长。因此,考虑到上述因素,该国市场的增长可能在预测期内在欧洲地区贡献最大份额。

欧洲其他地区下一代测序市场收入和预测到 2025 年(百万美元)

欧洲下一代测序排序 - 市场细分


按产品


•消耗品
•服务
•平台

按技术


•基因组测序
•外显子组测序
•重测序与靶向测序
•其他

按应用


•诊断
•药物发现
•精准医疗
•其他

最终用户


•学术与研究院
•医药及生物科技公司
•医院及诊所
•其他

按地理位置


•欧洲
•英国
•德国
•法国

公司简介


• Illumina, Inc.
•赛默飞世尔
• Qiagen NV,
•北京华大基因
•珀金埃尔默公司
• F.Hoffman-La Roche Ltd.
•安捷伦科技
• Eurofins Scientific
•牛津纳米孔技术有限公司
• Macrogen 公司


Europe Next Generation Sequencing Strategic Insights

Strategic insights for Europe Next Generation Sequencing involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.

strategic-framework/europe-next-generation-sequencing-market-strategic-framework.webp
Get more information on this report

Europe Next Generation Sequencing Report Scope

Report Attribute Details
Market size in 2017 US$ 1,633.4 Million
Market Size by 2025 US$ 7,685.4 Million
Global CAGR (2018 - 2025) 21.4%
Historical Data 2015-2016
Forecast period 2018-2025
Segments Covered By 产品
  • 平台
  • 服务
  • 消耗品
By 服务
  • 基因组测序
  • 外显子组测序
  • 重测序
  • 靶向测序和其他测序技术
By 应用
  • 诊断
  • 药物研发
  • 精准医疗及其他应用
By 最终用户
  • 学术和研究机构
  • 制药和生物技术公司
  • 医院诊所和其他最终用户
Regions and Countries Covered 欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
Market leaders and key company profiles
  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.,
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
  • Get more information on this report

    Europe Next Generation Sequencing Regional Insights

    The regional scope of Europe Next Generation Sequencing refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.

    geography/europe-next-generation-sequencing-market-geography.webp
    Get more information on this report

    The List of Companies - Europe Next Generation Sequencing Market

    The List of Companies - Europe Next Generation Sequencing Market

    1. Illumina, Inc.
    2. Thermo Fisher
    3. Qiagen N.V.,
    4. Beijing Genomics Institute
    5. PerkinElmer, Inc.
    6. F.Hoffman-La Roche Ltd.
    7. Agilent Technologies
    8. Eurofins Scientific
    9. Oxford Nanopore Technologies Ltd.
    10. Macrogen Inc.
    Frequently Asked Questions
    How big is the Europe Next Generation Sequencing Market?

    The Europe Next Generation Sequencing Market is valued at US$ 1,633.4 Million in 2017, it is projected to reach US$ 7,685.4 Million by 2025.

    What is the CAGR for Europe Next Generation Sequencing Market by (2018 - 2025)?

    As per our report Europe Next Generation Sequencing Market, the market size is valued at US$ 1,633.4 Million in 2017, projecting it to reach US$ 7,685.4 Million by 2025. This translates to a CAGR of approximately 21.4% during the forecast period.

    What segments are covered in this report?

    The Europe Next Generation Sequencing Market report typically cover these key segments-

  • 产品 (平台, 服务, 消耗品)
  • 服务 (基因组测序, 外显子组测序, 重测序, 靶向测序和其他测序技术)
  • 应用 (诊断, 药物研发, 精准医疗及其他应用)
  • What is the historic period, base year, and forecast period taken for Europe Next Generation Sequencing Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Next Generation Sequencing Market report:

  • Historic Period : 2015-2016
  • Base Year : 2017
  • Forecast Period : 2018-2025
  • Who are the major players in Europe Next Generation Sequencing Market?

    The Europe Next Generation Sequencing Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Illumina, Inc.
  • Thermo Fisher
  • Qiagen N.V.,
  • Beijing Genomics Institute
  • PerkinElmer, Inc.
  • F.Hoffman-La Roche Ltd.
  • Agilent Technologies
  • Eurofins Scientific
  • Oxford Nanopore Technologies Ltd.
  • Macrogen Inc.
  • Who should buy this report?

    The Europe Next Generation Sequencing Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Next Generation Sequencing Market value chain can benefit from the information contained in a comprehensive market report.